According to our experimental results, increasing the content of TYP in the preparation may contribute to the efficacy of related preparations in the treatment of hyperlipidemia, and future studies on TYP‐related preparations can refer to our experimental results. This evidence concerns the gene DUSP4 and hyperlipidemia.